牛叉诊股

[{"date":"2026.11.12","stock":"1.25","trade":"-0.19","ind":"-0.67"},{"date":"2026.11.11","stock":"-1.07","trade":"-0.53","ind":"0.46"},{"date":"2026.11.10","stock":"1.43","trade":"0.88","ind":"0.08"},{"date":"2026.11.09","stock":"0.41","trade":"-0.20","ind":"0.32"},{"date":"2026.11.06","stock":"1.24","trade":"-0.80","ind":"-1.10"},{"date":"2026.11.05","stock":"0.31","trade":"1.29","ind":"0.10"},{"date":"2026.11.04","stock":"0.45","trade":"0.85","ind":"2.16"},{"date":"2026.11.03","stock":"3.80","trade":"0.44","ind":"-0.82"},{"date":"2026.11.02","stock":"0.22","trade":"1.93","ind":"1.08"},{"date":"2026.10.30","stock":"2.64","trade":"-0.03","ind":"-1.44"},{"date":"2026.10.29","stock":"0.64","trade":"-1.62","ind":"-0.82"},{"date":"2026.10.28","stock":"1.33","trade":"0.86","ind":"0.91"},{"date":"2026.10.27","stock":"-1.05","trade":"-2.32","ind":"-1.33"},{"date":"2026.10.26","stock":"1.02","trade":"0.48","ind":"0.19"},{"date":"2026.10.23","stock":"2.05","trade":"0.88","ind":"0.89"},{"date":"2026.10.22","stock":"-1.64","trade":"-2.52","ind":"-1.48"},{"date":"2026.10.21","stock":"-1.61","trade":"-0.15","ind":"-0.60"},{"date":"2026.10.20","stock":"-0.48","trade":"-0.28","ind":"0.12"},{"date":"2026.10.19","stock":"3.27","trade":"0.26","ind":"0.39"},{"date":"2026.10.16","stock":"-2.44","trade":"-0.12","ind":"0.24"},{"date":"2026.10.15","stock":"-3.72","trade":"-1.40","ind":"-1.59"}]

济川药业,上证指数,中药指数

压力支撑

该股压力位为29.39元，支撑位为28.82元。

[{"text":"\u538b\u529b\u4f4d","value":"29.39","date":1794412800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"28.82","date":1794412800,"color":"0x0b52a1"}]

多空趋势

多头行情中，并且有加速上涨趋势。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：4.0资金面打败了62%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力没有控盘。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

中药行业，近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。

更新时间：11月12日 20:30

机构今日流向(万元)	-1021.51	机构5日流向(万元)	-5295.80
机构10日流向(万元)	-1568.08	机构20日流向(万元)	-5959.88

机构持仓

2026-06-30 与 2025-12-31 相比，主力机构持仓量增加2114.70万股，其中基金净减仓11家，主力净增仓35家，请投资者中长期谨慎为宜。

截止2026-06-30，共355家主力机构（基金348家，一般法人4家，券商3家），持仓量总计66271.86万股，占流通A股72.14%
其中，基金持仓与2025-12-31相比：
增仓：75家，增持 2276.56万股
减仓：86家，减持 797.51万股
新出现在主力名单中：165家，持有1884.63万股
从主力名单中消失：130家，原持有2149.66万股

消息面诊股

诊断结果：5.5消息面打败了57%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	募资投向		2026-09-18
一般消息	分红转增	不分配不转增	2026-08-29
一般消息	股东大会	年度股东大会	2026-04-24
利好	分红转增	10派17.40元(含税)	2026-04-24
一般消息	资产重组	公司股权转让	2026-04-24

一年消息统计

	所有消息	重大消息	非重大消息
利好	1条	0条	1条
利空	0条	0条	0条

行业面诊股

诊断结果：7.8行业面打败了93%的股票中药行业最新资金流向

近10日来该行业走势不明显，明显跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，明显跑赢大盘。

[{"date":"2026.11.12","price":"-0.67","value":"-0.19"},{"date":"2026.11.11","price":"0.46","value":"-0.53"},{"date":"2026.11.10","price":"0.08","value":"0.88"},{"date":"2026.11.09","price":"0.32","value":"-0.20"},{"date":"2026.11.06","price":"-1.10","value":"-0.80"},{"date":"2026.11.05","price":"0.10","value":"1.29"},{"date":"2026.11.04","price":"2.16","value":"0.85"},{"date":"2026.11.03","price":"-0.82","value":"0.44"},{"date":"2026.11.02","price":"1.08","value":"1.93"},{"date":"2026.10.30","price":"-1.44","value":"-0.03"},{"date":"2026.10.29","price":"-0.82","value":"-1.62"},{"date":"2026.10.28","price":"0.91","value":"0.86"},{"date":"2026.10.27","price":"-1.33","value":"-2.32"},{"date":"2026.10.26","price":"0.19","value":"0.48"},{"date":"2026.10.23","price":"0.89","value":"0.88"},{"date":"2026.10.22","price":"-1.48","value":"-2.52"},{"date":"2026.10.21","price":"-0.60","value":"-0.15"},{"date":"2026.10.20","price":"0.12","value":"-0.28"},{"date":"2026.10.19","price":"0.39","value":"0.26"},{"date":"2026.10.16","price":"0.24","value":"-0.12"},{"date":"2026.10.15","price":"-1.59","value":"-1.40"}]

上证指数,中药行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	桂林三金	31.82%	-8.39%	6.9分
2	维康药业	26.40%	22.38%	6.4分
3	*ST香雪	21.11%	30.10%	5.8分
4	恩威医药	16.50%	4.57%	6.0分
5	盘龙药业	13.93%	13.26%	5.8分
6	济川药业	12.17%	3.28%	6.6分
7	达仁堂	8.57%	-6.36%	5.5分
8	片仔癀	8.41%	-4.01%	5.5分
9	步长制药	6.97%	-1.52%	6.0分
10	葵花药业	6.63%	-1.57%	5.9分
11	羚锐制药	5.51%	-4.96%	6.9分
12	信邦制药	4.21%	-4.19%	6.1分
13	新光药业	3.96%	0.74%	5.0分
14	云南白药	3.33%	-0.18%	6.7分
15	东阿阿胶	3.13%	-2.26%	6.6分
16	以岭药业	3.13%	-3.91%	6.0分
17	陇神戎发	2.45%	11.00%	5.6分
18	康美药业	2.33%	-3.65%	5.5分
19	健民集团	1.40%	-3.04%	6.2分
20	昆药集团	0.72%	-4.63%	4.8分
21	-	0.68%	2.07%	分
22	亚宝药业	0.29%	-2.40%	5.2分
23	马应龙	-0.20%	-2.44%	6.3分
24	三力制药	-0.46%	-3.63%	5.3分
25	吉林敖东	-0.88%	-3.00%	5.3分
26	天士力	-0.92%	-3.32%	6.1分
27	华润江中	-1.09%	-2.50%	6.8分
28	ST嘉应	-1.50%	2.18%	5.4分
29	-	-1.79%	0.00%	分
30	华润三九	-1.84%	-3.43%	6.3分
31	奇正藏药	-1.98%	-3.88%	5.2分
32	康缘药业	-2.01%	-5.22%	6.1分
33	白云山	-2.11%	-3.47%	5.9分
34	方盛制药	-2.26%	-3.69%	5.6分
35	ST百灵	-2.67%	-2.24%	4.1分
36	康恩贝	-2.82%	-4.83%	5.1分
37	众生药业	-3.05%	2.31%	5.7分
38	ST葫芦娃	-3.06%	1.32%	5.2分
39	同仁堂	-3.23%	-6.15%	4.9分
40	红日药业	-3.42%	-5.47%	4.8分
41	仁和药业	-3.47%	-3.29%	5.1分
42	中恒集团	-3.48%	-0.89%	5.2分
43	振东制药	-3.81%	-1.64%	5.4分
44	太极集团	-4.61%	-3.81%	5.4分
45	珍宝岛	-4.86%	-3.74%	4.9分
46	千金药业	-4.95%	-1.01%	6.1分
47	寿仙谷	-5.19%	-1.23%	4.9分
48	新天药业	-5.20%	-0.52%	5.3分
49	华森制药	-5.64%	-0.37%	5.8分
50	佐力药业	-5.71%	-2.86%	5.5分
51	上海凯宝	-5.75%	-3.26%	5.2分
52	特一药业	-5.86%	0.00%	5.4分
53	九芝堂	-5.98%	-2.80%	6.3分
54	汉森制药	-6.15%	0.89%	5.9分
55	佛慈制药	-6.59%	-3.47%	5.7分
56	太龙药业	-7.24%	-2.39%	5.1分
57	ST金花	-7.35%	-2.25%	4.9分
58	益佰制药	-7.49%	-1.83%	5.0分
59	古汉医药	-8.00%	-1.12%	4.4分
60	沃华医药	-8.81%	-1.32%	6.3分
61	粤万年青	-9.84%	2.23%	4.8分
62	益盛药业	-10.25%	-1.63%	5.0分
63	华神科技	-11.11%	0.00%	5.0分
64	精华制药	-11.39%	-1.82%	5.3分
65	广誉远	-11.72%	-4.85%	5.4分
66	康惠股份	-13.91%	-1.65%	4.6分
67	ST万邦	-16.23%	5.09%	5.8分
68	天目药业	-23.98%	-3.65%	4.9分

<上一页 1 2 3 4 5...12 下一页>

行业评级

最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

综合评级

研究机构	评级日期	最新评级	上次评级
中信建投	2012-09-10	增持	增持
中信证券	2012-09-10	增持	增持
申银万国	2012-09-10	增持	增持
国都证券	2012-09-10	增持	-
长江证券	2012-09-09	增持	增持

基本面诊股

诊断结果：6.3基本面打败了67%的股票连续3年业绩增长30%的公司

该公司运营状况尚可，多数机构认为该股长期投资价值较高，投资者可加强关注。

个股深一度

潜在高分红能力：强（100分）

基本面得分最高的股票

[ 截止日期：2026-09-30 ]公司经营

盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 25/110 ， 3/110。

[{"date":"2026-09-30","value":"7.39","vol":"4.23"},{"date":"2026-06-30","value":"5.52","vol":"3.25"},{"date":"2026-03-31","value":"2.70","vol":"2.21"},{"date":"2025-12-31","value":"12.13","vol":"-2.33"},{"date":"2025-09-30","value":"7.17","vol":"4.80"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
净资产收益率(%)	7.39	5.52	2.70	12.13	7.17
行业(%)	4.23	3.25	2.21	-2.33	4.80

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2026-09-30","value":"79.81","vol":"52.92"},{"date":"2026-06-30","value":"79.48","vol":"53.70"},{"date":"2026-03-31","value":"82.12","vol":"55.05"},{"date":"2025-12-31","value":"78.95","vol":"52.85"},{"date":"2025-09-30","value":"76.28","vol":"53.29"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
销售毛利率(%)	79.81	79.48	82.12	78.95	76.28
行业(%)	52.92	53.70	55.05	52.85	53.29

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 38/110 ， 27/110。

[{"date":"2026-09-30","value":"-7.50","vol":"-8.01"},{"date":"2026-06-30","value":"-15.29","vol":"-9.08"},{"date":"2026-03-31","value":"-20.84","vol":"-5.58"},{"date":"2025-12-31","value":"-22.43","vol":"-6.76"},{"date":"2025-09-30","value":"-32.27","vol":"-7.84"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
营业收入同比增长率(%)	-7.50	-15.29	-20.84	-22.43	-32.27
行业(%)	-8.01	-9.08	-5.58	-6.76	-7.84

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2026-09-30","value":"3.77","vol":"-22.29"},{"date":"2026-06-30","value":"8.26","vol":"-101.51"},{"date":"2026-03-31","value":"-9.13","vol":"1.06"},{"date":"2025-12-31","value":"-29.77","vol":"-80.25"},{"date":"2025-09-30","value":"-46.27","vol":"-2.78"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
净利润同比增长率(%)	3.77	8.26	-9.13	-29.77	-46.27
行业(%)	-22.29	-101.51	1.06	-80.25	-2.78

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 53/110 ， 19/110。

[{"date":"2026-09-30","value":"0.21","vol":"0.33"},{"date":"2026-06-30","value":"0.13","vol":"0.22"},{"date":"2026-03-31","value":"0.07","vol":"0.12"},{"date":"2025-12-31","value":"0.34","vol":"0.47"},{"date":"2025-09-30","value":"0.22","vol":"0.35"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
总资产周转率(次)	0.21	0.13	0.07	0.34	0.22
行业(次)	0.33	0.22	0.12	0.47	0.35

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2026-09-30","value":"2.04","vol":"1.72"},{"date":"2026-06-30","value":"1.35","vol":"1.14"},{"date":"2026-03-31","value":"0.64","vol":"0.59"},{"date":"2025-12-31","value":"2.98","vol":"2.34"},{"date":"2025-09-30","value":"2.04","vol":"1.72"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
存货增长率(次)	2.04	1.35	0.64	2.98	2.04
行业(次)	1.72	1.14	0.59	2.34	1.72

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2026-09-30","value":"10.35","vol":"13.37"},{"date":"2026-06-30","value":"-2.30","vol":"20.65"},{"date":"2026-03-31","value":"72.91","vol":"5.83"},{"date":"2025-12-31","value":"21.64","vol":"30.77"},{"date":"2025-09-30","value":"-22.73","vol":"10.53"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
现金流量净额/营业收入	10.35	-2.30	72.91	21.64	-22.73
行业	13.37	20.65	5.83	30.77	10.53

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2026-09-30","value":"","vol":"0.00"},{"date":"2026-06-30","value":"1.35","vol":"0.88"},{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.31","vol":"1.00"},{"date":"2025-09-30","value":"","vol":"0.00"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
资本支出／折旧和摊销	-	1.35	-	0.31	-
行业	0.00	0.88	0.00	1.00	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 55/110 ， 61/110。

[{"date":"2026-09-30","value":"4.88","vol":"3.18"},{"date":"2026-06-30","value":"4.52","vol":"3.10"},{"date":"2026-03-31","value":"5.46","vol":"2.97"},{"date":"2025-12-31","value":"4.93","vol":"2.94"},{"date":"2025-09-30","value":"5.32","vol":"3.09"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
流动比率	4.88	4.52	5.46	4.93	5.32
行业	3.18	3.10	2.97	2.94	3.09

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2026-09-30","value":"4.71","vol":"2.39"},{"date":"2026-06-30","value":"4.36","vol":"2.34"},{"date":"2026-03-31","value":"5.29","vol":"2.23"},{"date":"2025-12-31","value":"4.81","vol":"2.15"},{"date":"2025-09-30","value":"5.16","vol":"2.24"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
速动比率	4.71	4.36	5.29	4.81	5.16
行业	2.39	2.34	2.23	2.15	2.24

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 49/110 ， 51/110。

[{"date":"2026-09-30","value":"17.50","vol":"31.42"},{"date":"2026-06-30","value":"18.78","vol":"32.07"},{"date":"2026-03-31","value":"15.82","vol":"31.94"},{"date":"2025-12-31","value":"17.33","vol":"32.43"},{"date":"2025-09-30","value":"16.18","vol":"31.59"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
资产负债率(%)	17.50	18.78	15.82	17.33	16.18
行业(%)	31.42	32.07	31.94	32.43	31.59

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2026-09-30","value":"0.21","vol":"0.67"},{"date":"2026-06-30","value":"0.23","vol":"0.68"},{"date":"2026-03-31","value":"0.19","vol":"0.66"},{"date":"2025-12-31","value":"0.21","vol":"0.67"},{"date":"2025-09-30","value":"0.19","vol":"0.76"}]

	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
产权比率 (%)	0.21	0.23	0.19	0.21	0.19
行业(%)	0.67	0.68	0.66	0.67	0.76

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。

研究机构	评级日期	最新评级	上次评级
国联民生	2026-11-10	买入
长城证券	2026-11-05	买入	买入
国金证券	2026-10-30	买入	买入
开源证券	2026-08-31	买入

机构预测

机构预测该股2026年每股收益与前一年相同，长期投资价值一般。

[{"date":"2022","yellowRectValue":"21.71","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"28.23","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"25.32","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"17.78","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"17.54","blueLineValue":"1.90","type":"YC"}]

[济川药业]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]